| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/30/2004 | WO2003104766A3 Method for enhancing dna base-calling accuracy |
| 09/30/2004 | WO2003101278A3 Device and method of use for detection and characterization of pathogens and biological materials |
| 09/30/2004 | WO2003083055A3 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | WO2003074739A3 Automated allele determination using fluorometric genotyping |
| 09/30/2004 | WO2003073097A3 Methods for isolating ligands e.g. t cell epitopes |
| 09/30/2004 | WO2003072740A3 Novel type-1 cytokine receptor glm-r |
| 09/30/2004 | WO2003062447A3 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 09/30/2004 | WO2003054016A8 Method for cloning of variable domain sequences |
| 09/30/2004 | WO2003049530A3 Method and apparatus for washing magnetically responsive particles |
| 09/30/2004 | WO2003048332A3 METHODS FOR ANALYZING METHYLATED CpG ISLANDS AND GC RICH REGIONS |
| 09/30/2004 | WO2003046126A3 Artificial genes for use as controls in gene expression analysis systems |
| 09/30/2004 | WO2003036299A8 Procedure for quantitative determination of viral or bacterial particles having a cholesterol-containing envelope |
| 09/30/2004 | WO2003031930A3 A phosphatase associated with metastasis |
| 09/30/2004 | WO2003014323A3 Human smooth muscle myosin heavy chain |
| 09/30/2004 | US20040194176 can be propagated vegetatively through suckers for commercial cultivation |
| 09/30/2004 | US20040194161 Methods of transforming plants and identifying parental origin of a chromosome in those plants |
| 09/30/2004 | US20040193310 Removing small items from a cartridge based restricted access dispenser system |
| 09/30/2004 | US20040192901 Using superoxide dismutase to identify modulators for treatment of diabetes, scrapies, transmissible spongiform encephalopathies and alzheimer's diseases |
| 09/30/2004 | US20040192893 comprises cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes for use in labeling nucleic acids or proteins in assay, and as diagnostic aid in genomics/proteomics |
| 09/30/2004 | US20040192645 detecting chitin in mammals; useful for diagnosing disease caused by accumulation of chitin or amyloid plaques such as Alzheimer's disease, spongiform encepalopathies, type II diabetes, atrial amyloidosis; administering the composition to inhibit polymerization of N-acetylglucosamine to chitin |
| 09/30/2004 | US20040192632 comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with the Non-Immunogenic or High Molecular Weight Compound |
| 09/30/2004 | US20040192607 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 09/30/2004 | US20040192601 Lipid binding molecules and methods of use |
| 09/30/2004 | US20040192591 Composition for treating Chlamydia infections and method for identifying same |
| 09/30/2004 | US20040191926 Ptp1b inhibitors and ligands |
| 09/30/2004 | US20040191905 Modulation of HIV replication by RNA interference |
| 09/30/2004 | US20040191884 Photoprotein derived from okinawan squid and gene encoding the photoprotein |
| 09/30/2004 | US20040191883 Comprises water soluble glucose dehydrogenase associated with pyrroloquinoline quinine as a coenzyme for use as diagnostic tool in bioassay for monitoring blood glucose concentration |
| 09/30/2004 | US20040191874 Process for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| 09/30/2004 | US20040191873 Determining transcription profile for cell with simultaneous identification of intron/exon boundaries; functional genomics and transcriptomics |
| 09/30/2004 | US20040191870 Methods of 6-0 sulfating polysaccharides and 6-0 sulfated polysaccharide preparations |
| 09/30/2004 | US20040191859 Fluorescent virus probes for identification of bacteria |
| 09/30/2004 | US20040191856 Using batch processing comprising biomolecules fixed to solid support and air pressure/zones to reduce sample loss in chemical process; microfluidics and enzyme reactions |
| 09/30/2004 | US20040191852 Methods for the identification of inhibitors of NADPH:protochlorophyllide oxidoreductase activity in plants |
| 09/30/2004 | US20040191851 Methods for the identification of inhibitors of lipid transfer protein activity in plants |
| 09/30/2004 | US20040191850 Nucleic acid molecules encoding proteins essential for plant growth and development and uses thereof |
| 09/30/2004 | US20040191849 Method for identifying fungicides |
| 09/30/2004 | US20040191844 Fluorescent dyes for intracellular detection of enzyme activity associated with apoptosis |
| 09/30/2004 | US20040191838 Sulfonyl ester compound for modifying catalase catalytic activity in order to determine microbial contamination of foodstuffs and cooling lubricants; screening efficacy of biocides |
| 09/30/2004 | US20040191835 Screening method for identifying ligands for target proteins |
| 09/30/2004 | US20040191829 Comprises peptide associated with sugar transport protein for identifying modulators for treatment and prevention of cell proliferative disorder |
| 09/30/2004 | US20040191828 Microarray for detecting variously spliced transcription products; gene expression profiles and diagnosis of metabolic and cell proliferative disorders |
| 09/30/2004 | US20040191827 Modulators of the hypocretin system and methods of screening therefor |
| 09/30/2004 | US20040191826 Dipeptidyl peptidases |
| 09/30/2004 | US20040191823 Universal e-tag primer and probe compositions and methods |
| 09/30/2004 | US20040191822 Using restriction fragment length polymorphisms in cytochrome genes to screen for multidrug resistance; tools for monitoring allelic variation generated via exposue to fexofenadine and cyclosporine |
| 09/30/2004 | US20040191821 Detection of nucleic acid sequence variations using phase MU transposase |
| 09/30/2004 | US20040191819 Expression profiles for breast cancer and methods of use |
| 09/30/2004 | US20040191818 Compositions and methods for diagnosing and treating autoimmune diseases |
| 09/30/2004 | US20040191817 Use of intronic RNA to measure gene expression |
| 09/30/2004 | US20040191816 Microarray for propagation of preferential nucleotide sequences for subsequent transformation into animal cells; forensics; medicine and epidemiology; public health and prediction, diagnosis and prevention of disease |
| 09/30/2004 | US20040191815 Array having oligonucleotides on a metal substrate |
| 09/30/2004 | US20040191814 Methods for recycling mRNA for linear cRNA amplification |
| 09/30/2004 | US20040191813 Comparative genomic hybridization assays using immobilized oligonucleotide features and compositions for practicing the same |
| 09/30/2004 | US20040191812 Target-dependent transcription using deletion mutants of N4 RNA polymerase |
| 09/30/2004 | US20040191811 Methods for measuring levels of uridine-diphosphate-N-acetylglucosamine and activity of inhibitors thereof |
| 09/30/2004 | US20040191810 Multicompartment microfluidic apparatus for detection restriction fragment length polymorphisms; genotyping and high throughput assays; genomics and gene expression analysis |
| 09/30/2004 | US20040191809 Methods for registration at the nanometer scale |
| 09/30/2004 | US20040191807 Automated high-throughput microarray system |
| 09/30/2004 | US20040191806 Assays using crosslinkable immobilized nucleic acids |
| 09/30/2004 | US20040191805 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment |
| 09/30/2004 | US20040191803 Preparing animal models and testing compounds for treatment of age related cognitive impairment; gene therapy and alzheimer's disease |
| 09/30/2004 | US20040191802 Phospholamban polymorphism and methods of assessment |
| 09/30/2004 | US20040191801 Reagentless, reusable bioelectronic detectors and their use as authentication devices |
| 09/30/2004 | US20040191798 Optineurin and glaucoma |
| 09/30/2004 | US20040191796 8-(3-{[bis(methylethyl)amino](2-cyanoethoxy)phosphinooxy}propyl)- 7-oxophenoxazin-3-yl 2,2-dimethylpropanoate; improves signal to noise ratios and other advantageous characteristics in hybridization and related assays |
| 09/30/2004 | US20040191794 Method for the determination of multiple analytes |
| 09/30/2004 | US20040191792 Acridone derivatives as labels for fluorescence detection of target materials |
| 09/30/2004 | US20040191791 Comprises nucleotide sequences coding sodium voltage gated channels for identifying modulators for treatment of epilepsy; diagnosis of seizure disorders |
| 09/30/2004 | US20040191788 Method of encoding information in nucleic acids of a genetically enginerred organism |
| 09/30/2004 | US20040191786 Three cube fret method (3-fret) for detecting fluorescence energy transfer |
| 09/30/2004 | US20040191785 Methods for diagnosing individuals with an increased risk to develop a deficiency based on mdr1 gene polymorphism |
| 09/30/2004 | US20040191784 Composition comprising reporter binding agent, amplification DNA target circle and polymerase for propagation and labeling of preferential nucleotide sequences |
| 09/30/2004 | US20040191783 Solid support comprising plurality of capture molecules for detection, diagnosis and prognosis of cell proliferative disorders; hormonal viariation and tumor propagation |
| 09/30/2004 | US20040191782 Evaluating colon tumors for recurrence via differential gene expression of tumor antigen genes in bowel cell walls; cancer diagnosis and treatments; antitumor agents |
| 09/30/2004 | US20040191781 Genomic profiling of regulatory factor binding sites |
| 09/30/2004 | US20040191779 Statistical analysis of regulatory factor binding sites of differentially expressed genes |
| 09/30/2004 | US20040191778 Colloidal silver-biomolecule complexes |
| 09/30/2004 | US20040191777 Apparatus and methods for isolating droplet dispensing devices |
| 09/30/2004 | US20040191776 Method for genotyping and quantifying Hepatitis B Virus |
| 09/30/2004 | US20040191775 Methods of analyzing genes affected by caloric restriction or caloric restriction mimetics |
| 09/30/2004 | US20040191774 Endothelin-1 promoter polymorphism |
| 09/30/2004 | US20040191773 Oligoribonucleotides and ribonucleases for cleaving RNA |
| 09/30/2004 | US20040191772 Method of shuffling polynucleotides using templates |
| 09/30/2004 | US20040191770 Biological particulate matter analogue |
| 09/30/2004 | US20040191769 Methods, compositions, and kits for mutation detection in mitochondrial DNA |
| 09/30/2004 | US20040191768 Process for typing of HCV isolates |
| 09/30/2004 | US20040191766 Using fusion protein comprised of terminal reporter molecules to detect virusbinding and entry into cells; receptor-dependent targeted therapy; viricides |
| 09/30/2004 | US20040191764 Using alteration in leukocyte common antigen expression to identify allelic variation which increases human susceptibility to viral infection/disease; diagnosing autoimmune disorders |
| 09/30/2004 | US20040191760 Lateral flow rapid immunoassay test device |
| 09/30/2004 | US20040191756 Transgenic rodent for diagnosing and identifying modulator for treatment and prevention inflammatory disorders |
| 09/30/2004 | US20040191268 Isolated, synthetic or recombinant nonapeptide of a minor Histocompatability antigen HA-1 comprising the sequence valine-leucine-X-aspartic acid-aspartic acid-leucine-leucine-glutamic acid-alanine wherein X is arginine or histidine; bone marrow transplants; graft versus host disease; leukemia |
| 09/30/2004 | US20040191249 Exposing tumor to ionizing radiation; administering drug library; isolating binding drug; cancer diagnosis; drug screening |
| 09/30/2004 | US20040191230 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin |
| 09/30/2004 | US20040191228 Methods of kidney transplantation utilizing developing nephric tissue |
| 09/30/2004 | US20040191223 Combinatorial methods for inducing cancer cell death |
| 09/30/2004 | US20040191173 Metastasis models using green fluorescent protein (GFP) as a marker |
| 09/30/2004 | US20040191171 Method of detecting skin stimulation effect |
| 09/30/2004 | US20040189989 Method for detection of pathogenic microorganisms |